Stocks Hitting 52-Week Lows
October 18, 2013 at 10:01 AM EDT
Ariad Pharmaceuticals (NASDAQ: ARIA ) shares reached a new 52-week low of $2.735 after the company announced discontinuation of the Phase 3 EPIC trial of Iclusig. Acacia Research (NASDAQ: ACTG ) shares dropped 22.91% to touch a new 52-week low of $15.13 after the company reported Q3 results. Stephens
